GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,733.50p
   
  • Change Today:
      5.00p
  • 52 Week High: 1,743.00
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,144.92m
  • Volume: 4,237,111
  • Market Cap: £71,852m
  • RiskGrade: 129

Sunday newspaper round-up: Renewi, Metro Bank, New homes

By Alexander Bueso

Date: Sunday 08 Oct 2023

LONDON (ShareCast) - (Sharecast News) - Some of Renewi's major shareholders are divided as to whether the recycling company should engage with Australian suitor Macquarie. One major shareholder has told Renewi's board that it should not until Macquarie raised its £636m bid, but another top ten shareholder told The Sunday Times that it should talk to the Australian outfit anyways. Macquarie has until 26 October to make a firm offer. - The Sunday Times
Metro Bank is engaged in marathon talks with its bondholders to clinch a refinancing deal before the market open in London. The lender is reportedly seeking a £600m lifeline and needs to refinance £350m of debt within a year. It just recently balked at a takeover approach from Shawbrook, according to Sky News. Failure to close a deal may force it to sell the majority of its mortgage book, analysts at Barclays estimated, assuming the loans were sold at face value, which would be a challenge if seen as a forced sale. - The Financial Mail on Sunday

Labour will set a target to build 1.5m new homes over the next five years, party leader Keir Starmer said. It would also strengthen guidance to ensure developers to ensure that enough affordable homes were included. His party would also review the regulations regarding building on the green belt. In parallel, shadow Chancellor Rachel Reeves told the Sunday Times a common sense approach was necessary when designating land as greenbelt and brownfield. - Guardian

GSK is preparing to reorganise its research teams, switching from a single unit to individual teams for three areas: vaccines and infectious diseases, respiratory and immunology and oncology. The teams would also focus on earlier-stage science and then pass promising treatments to development teams. The company said however that "very few" redundancies would result from the changes. - The Sunday Times

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,733.50p
Change Today 5.00p
% Change 0.29 %
52 Week High 1,743.00
52 Week Low 1,316.00
Volume 4,237,111
Shares Issued 4,144.92m
Market Cap £71,852m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
25.74% above the market average25.74% above the market average25.74% above the market average25.74% above the market average25.74% above the market average
68.63% above the sector average68.63% above the sector average68.63% above the sector average68.63% above the sector average68.63% above the sector average
Price Trend
49.19% above the market average49.19% above the market average49.19% above the market average49.19% above the market average49.19% above the market average
70.91% above the sector average70.91% above the sector average70.91% above the sector average70.91% above the sector average70.91% above the sector average
Income
8.79% above the market average8.79% above the market average8.79% above the market average8.79% above the market average8.79% above the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
22.96% below the market average22.96% below the market average22.96% below the market average22.96% below the market average22.96% below the market average
37.14% above the sector average37.14% above the sector average37.14% above the sector average37.14% above the sector average37.14% above the sector average

What The Brokers Say

Strong Buy 8
Buy 5
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 16-May-24 22-Feb-24
Paid 11-Jul-24 11-Apr-24
Amount 15.00p 16.00p

Trades for 03-May-2024

Time Volume / Share Price
15:21 6 @ 1,731.50p
15:01 0 @ 1,733.50p
16:49 185 @ 1,733.50p
16:35 1,624,313 @ 1,733.50p
16:35 2,000 @ 1,733.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page